Efficacy and safety of immune checkpoint inhibitor consolidation after chemoradiation in patients of Asian ethnicity with unresectable stage III non‐small cell lung cancer: Chinese multicenter report and literature review

BACKGROUND: The PACIFIC study has defined a new standard of care for patients with unresectable stage III non‐small cell lung cancer (NSCLC) in the form of immune checkpoint inhibitor (ICI) consolidation therapy. However, there is little specific data pertaining to the safety and efficacy of this ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Tao, Xu, Kunpeng, Bi, Nan, Zhang, Li, Jiang, Wei, Liang, Jun, Deng, Lei, Wang, Xin, Wang, Jianyang, Wang, Jie, Wang, Luhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529561/
https://www.ncbi.nlm.nih.gov/pubmed/32833338
http://dx.doi.org/10.1111/1759-7714.13631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529561/
https://www.ncbi.nlm.nih.gov/pubmed/32833338
http://dx.doi.org/10.1111/1759-7714.13631

Ejemplares similares